ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer

NCT02009579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Neoplasms

Interventions

DRUG: Nintedanib
DRUG: Placebo

Sponsor

Belgian Gynaecological Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]